RWM
TMO icon

Riverbend Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Riverbend Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
930
+95
+11% +$45.6K 0.23% 111
2026
Q1 		$411K Buy
835
+29
+4% +$15.7K 0.24% 102
2025
Q4 		$467K Buy
806
+50
+7% +$28.3K 0.29% 90
2025
Q3 		$366K Buy
756
+35
+5% +$16.3K 0.26% 91
2025
Q2 		$292K Buy
721
+54
+8% +$22.6K 0.22% 111
2025
Q1 		$332K Buy
667
+68
+11% +$36.8K 0.3% 89
2024
Q4 		$312K Buy
+599
New +$329K 0.28% 89

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Riverbend Wealth Management's TMO Position: Q2 2026 in Review

Riverbend Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $45.6K and bringing the position to 930 shares worth $466K. The position accounts for 0.23% of the portfolio, ranked #111.

Riverbend Wealth Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $467K in Q4 2025. 1,197 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Riverbend Wealth Management held 930 shares of Thermo Fisher Scientific worth $466K as of Q2 2026.
  • Riverbend Wealth Management bought 95 Thermo Fisher Scientific shares in Q2 2026, an estimated $45.6K.
  • Thermo Fisher Scientific made up 0.23% of Riverbend Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Riverbend Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Riverbend Wealth Management's Thermo Fisher Scientific position peaked at $467K in Q4 2025.
  • 1,197 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Riverbend Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.